Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-12-15 LO FRANCIS Chief People Officer Sale −241 $57.01 $14K 0
2020-12-15 LO FRANCIS Chief People Officer Option exercise · Stock Option (Right To Buy) −2,000 161,000
2020-12-14 VIKING GLOBAL INVESTORS LP 10% owner Sale −1,000,000 $55.65 $55.6M 29,993,708
2020-12-14 HILL NANCY LOUISE EVP, Operations & Program Mana Option exercise +40,000 $0.84 $34K 50,000
2020-12-14 HILL NANCY LOUISE EVP, Operations & Program Mana Sale −40,000 $59.00 $2.4M 10,000
2020-12-14 HILL NANCY LOUISE EVP, Operations & Program Mana Option exercise · Stock Option (Right to Buy) −40,000 59,000
2020-12-14 GRIFFIN MICHELLE RENEE Director Option exercise +6,000 $7.80 $47K 6,000
2020-12-14 GRIFFIN MICHELLE RENEE Director Sale −982 $57.42 $56K 5,018
2020-12-14 GRIFFIN MICHELLE RENEE Director Sale −3,367 $58.96 $199K 1,651
2020-12-14 GRIFFIN MICHELLE RENEE Director Sale −1,651 $59.44 $98K 0
2020-12-14 GRIFFIN MICHELLE RENEE Director Option exercise · Stock Option (Right to Buy) −6,000 101,000
2020-12-11 SANG CHARLES SVP, External Affairs Option exercise +50,000 $6.55 $328K 50,000
2020-12-11 SANG CHARLES SVP, External Affairs Sale −50,000 $56.13 $2.8M 0
2020-12-11 SANG CHARLES SVP, External Affairs Option exercise · Stock Option (Right to Buy) −50,000 155,000
2020-12-10 BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ Option exercise +25,000 $1.98 $50K 25,000
2020-12-10 BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ Sale −25,000 $55.00 $1.4M 0
2020-12-10 BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ Option exercise · Stock Option (Right to Buy) −25,000 30,000
2020-12-08 Cohen Chad M Chief Financial Officer Option exercise +30,000 $6.32 $190K 31,000
2020-12-08 Cohen Chad M Chief Financial Officer Sale −20,256 $50.88 $1.0M 10,744
2020-12-08 Cohen Chad M Chief Financial Officer Sale −9,444 $51.98 $491K 1,300

Page 80 of 120 · 2,386 trades